West to present on development of large volume delivery systems, self-injection devices and prefillable syringe component expertise at the pda conference

Expert presentations and posters offer thought leadership in drug delivery innovation, patient adherence and pharmaceutical manufacturing exton, pa. , oct. 18, 2022 /prnewswire/ --  west pharmaceutical services, inc. (nyse: wst), a global leader in innovative solutions for injectable drug administration, today announced participation in the 2022 pda universe of pre-filled syringes and injection devices conference to showcase its leadership and expertise on industry challenges and trends in packaging and containment.
WST Ratings Summary
WST Quant Ranking